Prestige Consumer Healthcare Earnings
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$1.06
Prestige Consumer Healthcare earnings summary
Prestige Consumer Healthcare is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $1.06. In its most recent report on Aug 6, 2026 (Q1 2027), PBH posted EPS of $0.61. Revenue for the quarter was $265.7 million.
Quarterly EPS is down 35.8% from the same quarter a year earlier. Across the last 16 reports, PBH shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
PBH earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $0.61 | — | -6.3% |
| May 13, 2026 | — | $1.13 | — | +2.7% |
| Feb 5, 2026 | — | $0.97 | — | +0.7% |
| Nov 6, 2025 | — | $0.86 | — | +0.1% |
| Aug 7, 2025 | — | $0.95 | — | -0.9% |
| May 8, 2025 | — | $1.00 | — | +2.1% |
| Feb 6, 2025 | — | $1.22 | — | -1.1% |
| Nov 7, 2024 | — | $1.09 | — | +2.5% |
| Aug 8, 2024 | — | $0.98 | — | +3.5% |
| May 14, 2024 | — | $0.98 | — | -1.1% |
| Feb 8, 2024 | — | $1.06 | — | +0.7% |
| Nov 2, 2023 | — | $1.07 | — | -3.1% |
| Aug 3, 2023 | — | $1.06 | — | -4.0% |
| May 4, 2023 | — | $-4.80 | — | -2.9% |
| Feb 2, 2023 | — | $1.04 | — | -2.2% |
| Nov 3, 2022 | — | $1.02 | — | +3.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.